Who is sponsoring NCT02639598?

NCT02639598 is sponsored by Taipei Veterans General Hospital, Taiwan.

What condition does NCT02639598 study?

NCT02639598 studies Chronic Migraine.

What drugs are being tested in NCT02639598?

Interventions: Flunarizine, Topiramate.

What is the status of NCT02639598?

NCT02639598 is currently COMPLETED.

Last reviewed 2015-12-20 · How we verify

Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis

NCT02639598 Phase 4 COMPLETED

Chronic migraine (CM) is a prevalent and devastating disorder with limited therapeutic options. This study explored the efficacy of 10 mg/day flunarizine for CM prophylaxis as compared with 50 mg/day topiramate.

Details

Lead sponsor	Taipei Veterans General Hospital, Taiwan
Phase	Phase 4
Status	COMPLETED
Enrolment	62
Start date	2012-06
Completion	2015-03

Conditions

Chronic Migraine

Interventions

Flunarizine
Topiramate

Primary outcomes

reduction of total number of headache days (by diary log) — week 7 to 8 after treatment (T4) compared to week -2 to 0 before treatment (T0)
Patients were followed per 2 weeks at the Headache Clinic. At each visit, diaries were collected, and information within the diary was used for outcome measurement.
reduction of number of migraine days (by diary log) — week 7 to 8 after treatment (T4) compared to week -2 to 0 before treatment (T0)
Patients were followed per 2 weeks at the Headache Clinic. At each visit, diaries were collected, and information within the diary was used for outcome measurement.